PHILADELPHIA CHROMOSOME POSITIVE CML
Clinical trials for PHILADELPHIA CHROMOSOME POSITIVE CML explained in plain language.
Never miss a new study
Get alerted when new PHILADELPHIA CHROMOSOME POSITIVE CML trials appear
Sign up with your email to follow new studies for PHILADELPHIA CHROMOSOME POSITIVE CML, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for kids with rare blood cancer
Disease control OngoingThis study is testing a drug called bosutinib for children with a specific type of leukemia called Philadelphia chromosome-positive chronic myeloid leukemia (CML). It aims to find the right dose for kids and see how safe and effective it is, both for newly diagnosed patients and …
Matched conditions: PHILADELPHIA CHROMOSOME POSITIVE CML
Phase: PHASE1, PHASE2 • Sponsor: Children's Oncology Group • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC
-
New leukemia treatment strategy aims for a 'Drug Holiday'
Disease control OngoingThis study is testing a two-step treatment plan for adults newly diagnosed with a common type of chronic leukemia. First, patients take a stronger drug (ponatinib) for six months to deeply reduce the cancer. Then, they switch to a standard, gentler drug (imatinib) for up to three…
Matched conditions: PHILADELPHIA CHROMOSOME POSITIVE CML
Phase: PHASE2 • Sponsor: Centre Leon Berard • Aim: Disease control
Last updated Mar 24, 2026 12:01 UTC